Portfolio Holdings Detail for ISIN IE000D8XC064
| Stock Name / Fund | iShares World Equity Enhanced Active UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WOEE(GBP) LSE |
| ETF Ticker | WOEE.AS(USD) AS |
| ETF Ticker | WOEE.AS(USD) Euronext Amsterdam |
Holdings detail for JAZZ
| Stock Name | Jazz Pharmaceuticals PLC |
| Ticker | JAZZ(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | IE00B4Q5ZN47 |
Show aggregate JAZZ holdings
News associated with JAZZ
- Hsbc Holdings PLC Acquires 605 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Hsbc Holdings PLC boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 26.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,871 shares of the specialty pharmaceutical company’s stock after buying an additional 605 […] - 2025-05-09 08:34:54
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Townsquare Capital LLC
- Townsquare Capital LLC lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 79.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,540 shares of the specialty pharmaceutical company’s stock after buying an additional 1,568 shares during the quarter. Townsquare […] - 2025-04-21 08:00:54
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Bank of Montreal Can
- Bank of Montreal Can reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,194 shares of the specialty pharmaceutical company’s stock after selling 2,253 shares during the period. Bank of […] - 2025-04-17 08:42:52
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MN
- Wells Fargo & Company MN lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.1% during the fourth quarter, HoldingsChannel reports. The fund owned 96,952 shares of the specialty pharmaceutical company’s stock after selling 20,063 shares during the period. Wells Fargo & Company MN’s holdings in Jazz Pharmaceuticals were worth […] - 2025-04-16 08:27:14
- Fmr LLC Has $91.42 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Fmr LLC cut its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 742,305 shares of the specialty pharmaceutical company’s stock after selling 93,576 shares during the period. Fmr LLC […] - 2025-04-16 07:34:53
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Recommendation of “Moderate Buy” by Brokerages
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month target […] - 2025-04-13 08:34:43
- 5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath
- ANET, GLW, JAZZ, AES and PPC are some of the stocks with high ROE to profit from as markets recoiled on tariff war. - 2025-04-07 14:02:00
- Sei Investments Co. Has $7.54 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Sei Investments Co. decreased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 30.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,221 shares of the specialty pharmaceutical company’s stock after selling 26,878 shares during the period. […] - 2025-04-01 08:04:51
- Mitsubishi UFJ Trust & Banking Corp Purchases 7,963 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Mitsubishi UFJ Trust & Banking Corp boosted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 20.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,325 shares of the specialty pharmaceutical company’s stock after purchasing an additional 7,963 shares […] - 2025-03-31 08:40:54
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by American Century Companies Inc.
- American Century Companies Inc. raised its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 55.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 160,412 shares of the specialty pharmaceutical company’s stock after buying an additional 57,406 shares during the period. American Century Companies Inc.’s holdings in Jazz Pharmaceuticals were […] - 2025-03-31 07:48:54
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Bought by Envestnet Portfolio Solutions Inc.
- Envestnet Portfolio Solutions Inc. raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 3,146 shares of the specialty pharmaceutical company’s stock after purchasing an additional 502 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings […] - 2025-03-27 08:07:00
- Corient Private Wealth LLC Grows Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Corient Private Wealth LLC raised its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 34.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,857 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,784 shares during the quarter. Corient […] - 2025-03-26 10:06:52
- Avantax Advisory Services Inc. Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Avantax Advisory Services Inc. acquired a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,140 shares of the specialty pharmaceutical company’s stock, valued at approximately $264,000. A number of other hedge funds have also modified their holdings of JAZZ. IFP Advisors Inc […] - 2025-03-26 08:50:58
- PNC Financial Services Group Inc. Buys 374 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- PNC Financial Services Group Inc. grew its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 8.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,749 shares of the specialty pharmaceutical company’s stock after acquiring an additional 374 […] - 2025-03-19 08:03:21
- Atria Investments Inc Purchases 445 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Atria Investments Inc lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 19.5% during the fourth quarter, HoldingsChannel reports. The firm owned 2,732 shares of the specialty pharmaceutical company’s stock after purchasing an additional 445 shares during the period. Atria Investments Inc’s holdings in Jazz Pharmaceuticals were worth $336,000 as of its […] - 2025-03-18 08:54:52
- M&T Bank Corp Has $473,000 Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- M&T Bank Corp boosted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,835 shares of the specialty pharmaceutical company’s stock after purchasing an additional 246 shares during the period. M&T Bank Corp’s holdings in Jazz Pharmaceuticals were worth $473,000 at […] - 2025-03-14 08:08:54
- HC Wainwright Forecasts Strong Price Appreciation for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock
- Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target upped by HC Wainwright from $200.00 to $217.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other brokerages have also issued reports on JAZZ. JPMorgan Chase & […] - 2025-03-11 06:26:45
- Y Intercept Hong Kong Ltd Sells 10,068 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Y Intercept Hong Kong Ltd lessened its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 79.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,631 shares of the specialty pharmaceutical company’s stock after selling 10,068 shares […] - 2025-03-04 09:02:53
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by New York State Common Retirement Fund
- New York State Common Retirement Fund lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 5.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,273 shares of the specialty pharmaceutical company’s stock after selling […] - 2025-02-27 08:51:02
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Principal Financial Group Inc.
- Principal Financial Group Inc. decreased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 3.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 138,663 shares of the specialty pharmaceutical company’s stock after selling 4,275 shares during the quarter. Principal Financial Group Inc.’s holdings in Jazz Pharmaceuticals were worth $17,076,000 […] - 2025-02-26 09:20:55
- Truist Financial Corp Grows Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Truist Financial Corp increased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 19.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 28,549 shares of the specialty pharmaceutical company’s stock after buying an additional 4,723 shares during the period. Truist Financial […] - 2025-02-25 09:49:03
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Rhumbline Advisers
- Rhumbline Advisers raised its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 167,560 shares of the specialty pharmaceutical company’s stock after acquiring an additional 1,755 shares during […] - 2025-02-21 10:06:56
- State of New Jersey Common Pension Fund D Has $2.83 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- State of New Jersey Common Pension Fund D cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 3.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,939 shares of the specialty pharmaceutical company’s stock after selling 723 shares during the period. State of […] - 2025-02-21 09:18:56
- Blue Trust Inc. Raises Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Blue Trust Inc. raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 73.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,767 shares of the specialty pharmaceutical company’s stock after buying an additional 750 shares during the quarter. Blue Trust Inc.’s holdings in Jazz Pharmaceuticals were worth $218,000 at the […] - 2025-02-20 09:48:51
- Van ECK Associates Corp Decreases Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Van ECK Associates Corp decreased its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 18.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,379 shares of the specialty pharmaceutical company’s stock after selling 10,832 shares […] - 2025-02-18 08:36:59
- Bleakley Financial Group LLC Has $383,000 Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
- Bleakley Financial Group LLC raised its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 52.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,112 shares of the specialty pharmaceutical company’s stock after buying an additional […] - 2025-02-11 08:57:00
- 1,726 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Trust Point Inc.
- Trust Point Inc. purchased a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, Holdings Channel reports. The fund purchased 1,726 shares of the specialty pharmaceutical company’s stock, valued at approximately $213,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. […] - 2025-02-07 09:27:22
- Jazz Pharmaceuticals (NASDAQ:JAZZ) vs. Acrivon Therapeutics (NASDAQ:ACRV) Head to Head Analysis
- Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) and Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Risk & Volatility Acrivon Therapeutics has a beta […] - 2025-02-06 06:44:47
- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $177.00 Consensus PT from Brokerages
- Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The […] - 2025-01-31 07:06:54
iShares World Equity Enhanced Active UCITS ETF USD (Acc) JAZZ holdings
| Date | Number of JAZZ Shares Held | Base Market Value of JAZZ Shares | Local Market Value of JAZZ Shares | Change in JAZZ Shares Held | Change in JAZZ Base Value | Current Price per JAZZ Share Held | Previous Price per JAZZ Share Held |
|---|
| 2025-05-08 (Thursday) | 60 | USD 5,905 | USD 5,905 | 0 | USD -181 | USD 98.4167 | USD 101.433 |
| 2025-05-07 (Wednesday) | 60 | USD 6,086 | USD 6,086 | 0 | USD -584 | USD 101.433 | USD 111.167 |
| 2025-05-06 (Tuesday) | 60 | USD 6,670 | USD 6,670 | 0 | USD -421 | USD 111.167 | USD 118.183 |
| 2025-05-05 (Monday) | 60 | USD 7,091 | USD 7,091 | 0 | USD -112 | USD 118.183 | USD 120.05 |
| 2025-05-02 (Friday) | 60 | USD 7,203 | USD 7,203 | 0 | USD 172 | USD 120.05 | USD 117.183 |
| 2025-05-01 (Thursday) | 60 | USD 7,031 | USD 7,031 | 0 | USD 13 | USD 117.183 | USD 116.967 |
| 2025-04-30 (Wednesday) | 60 | USD 7,018 | USD 7,018 | 0 | USD 33 | USD 116.967 | USD 116.417 |
| 2025-04-29 (Tuesday) | 60 | USD 6,985 | USD 6,985 | 0 | USD 212 | USD 116.417 | USD 112.883 |
| 2025-04-28 (Monday) | 60 | USD 6,773 | USD 6,773 | 0 | USD 125 | USD 112.883 | USD 110.8 |
| 2025-04-25 (Friday) | 60 | USD 6,648 | USD 6,648 | 0 | USD 109 | USD 110.8 | USD 108.983 |
| 2025-04-24 (Thursday) | 60 | USD 6,539 | USD 6,539 | 0 | USD 288 | USD 108.983 | USD 104.183 |
| 2025-04-23 (Wednesday) | 60 | USD 6,251 | USD 6,251 | 0 | USD 48 | USD 104.183 | USD 103.383 |
| 2025-04-22 (Tuesday) | 60 | USD 6,203 | USD 6,203 | 0 | USD 183 | USD 103.383 | USD 100.333 |
| 2025-04-21 (Monday) | 60 | USD 6,020 | USD 6,020 | 0 | USD -147 | USD 100.333 | USD 102.783 |
| 2025-04-18 (Friday) | 60 | USD 6,167 | USD 6,167 | 0 | USD 0 | USD 102.783 | USD 102.783 |
| 2025-04-17 (Thursday) | 60 | USD 6,167 | USD 6,167 | 0 | USD 74 | USD 102.783 | USD 101.55 |
| 2025-04-16 (Wednesday) | 60 | USD 6,093 | USD 6,093 | 0 | USD -82 | USD 101.55 | USD 102.917 |
| 2025-04-15 (Tuesday) | 60 | USD 6,175 | USD 6,175 | 0 | USD 70 | USD 102.917 | USD 101.75 |
| 2025-04-14 (Monday) | 60 | USD 6,105 | USD 6,105 | 0 | USD 75 | USD 101.75 | USD 100.5 |
| 2025-04-11 (Friday) | 60 | USD 6,030 | USD 6,030 | 0 | USD -93 | USD 100.5 | USD 102.05 |
| 2025-04-10 (Thursday) | 60 | USD 6,123 | USD 6,123 | 0 | USD -484 | USD 102.05 | USD 110.117 |
| 2025-04-09 (Wednesday) | 60 | USD 6,607 | USD 6,607 | 0 | USD 438 | USD 110.117 | USD 102.817 |
| 2025-04-08 (Tuesday) | 60 | USD 6,169 | USD 6,169 | 0 | USD -247 | USD 102.817 | USD 106.933 |
| 2025-04-07 (Monday) | 60 | USD 6,416 | USD 6,416 | 0 | USD -186 | USD 106.933 | USD 110.033 |
| 2025-04-04 (Friday) | 60 | USD 6,602 | USD 6,602 | 44 | USD 4,579 | USD 110.033 | USD 126.438 |
| 2025-04-02 (Wednesday) | 16 | USD 2,023 | USD 2,023 | 0 | USD 23 | USD 126.438 | USD 125 |
| 2025-04-01 (Tuesday) | 16 | USD 2,000 | USD 2,000 | 0 | USD 14 | USD 125 | USD 124.125 |
| 2025-03-31 (Monday) | 16 | USD 1,986 | USD 1,986 | 0 | USD 19 | USD 124.125 | USD 122.938 |
| 2025-03-28 (Friday) | 16 | USD 1,967 | USD 1,967 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of JAZZ by Blackrock for IE000D8XC064
Show aggregate share trades of JAZZ| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-04-04 | BUY | 44 | | | 110.033* | | 125.19 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of JAZZ
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-05-09 | 322,202 | 0 | 447,890 | 71.9% |
| 2025-05-08 | 797,766 | 0 | 1,089,054 | 73.3% |
| 2025-05-07 | 1,189,953 | 1 | 1,598,133 | 74.5% |
| 2025-05-06 | 786,430 | 5,127 | 1,296,885 | 60.6% |
| 2025-05-05 | 530,104 | 8,100 | 722,564 | 73.4% |
| 2025-05-02 | 361,978 | 0 | 461,946 | 78.4% |
| 2025-05-01 | 534,306 | 503 | 646,445 | 82.7% |
| 2025-04-30 | 218,617 | 10 | 516,686 | 42.3% |
| 2025-04-29 | 345,817 | 0 | 448,475 | 77.1% |
| 2025-04-28 | 301,366 | 80 | 397,208 | 75.9% |
| 2025-04-25 | 231,806 | 17 | 333,248 | 69.6% |
| 2025-04-24 | 306,517 | 7,953 | 446,705 | 68.6% |
| 2025-04-23 | 261,750 | 18,900 | 387,344 | 67.6% |
| 2025-04-22 | 313,984 | 7,619 | 426,425 | 73.6% |
| 2025-04-21 | 155,339 | 58 | 262,886 | 59.1% |
| 2025-04-17 | 297,626 | 5,800 | 448,041 | 66.4% |
| 2025-04-16 | 197,298 | 5,364 | 361,569 | 54.6% |
| 2025-04-15 | 256,568 | 28,524 | 431,792 | 59.4% |
| 2025-04-14 | 259,696 | 146 | 414,460 | 62.7% |
| 2025-04-11 | 437,489 | 5,833 | 818,474 | 53.5% |
| 2025-04-10 | 612,364 | 14,100 | 1,158,192 | 52.9% |
| 2025-04-09 | 538,812 | 6 | 1,081,325 | 49.8% |
| 2025-04-08 | 322,074 | 224 | 578,536 | 55.7% |
| 2025-04-07 | 335,397 | 2,157 | 666,973 | 50.3% |
| 2025-04-04 | 409,457 | 0 | 973,482 | 42.1% |
| 2025-04-03 | 282,473 | 0 | 688,476 | 41.0% |
| 2025-04-02 | 287,125 | 12,948 | 469,139 | 61.2% |
| 2025-04-01 | 253,623 | 6 | 470,294 | 53.9% |
| 2025-03-31 | 348,703 | 183 | 733,150 | 47.6% |
| 2025-03-28 | 259,551 | 425 | 787,272 | 33.0% |
| 2025-03-27 | 400,091 | 0 | 689,182 | 58.1% |
| 2025-03-26 | 349,708 | 9,642 | 891,894 | 39.2% |
| 2025-03-25 | 375,748 | 11,897 | 636,743 | 59.0% |
| 2025-03-24 | 222,753 | 18,303 | 364,931 | 61.0% |
| 2025-03-21 | 212,486 | 0 | 285,524 | 74.4% |
| 2025-03-20 | 270,553 | 4,600 | 453,526 | 59.7% |
| 2025-03-19 | 530,976 | 439 | 706,517 | 75.2% |
| 2025-03-18 | 134,219 | 1,375 | 282,417 | 47.5% |
| 2025-03-17 | 264,874 | 254 | 330,837 | 80.1% |
| 2025-03-14 | 262,322 | 0 | 382,727 | 68.5% |
| 2025-03-13 | 310,529 | 0 | 441,643 | 70.3% |
| 2025-03-12 | 182,091 | 1 | 316,632 | 57.5% |
| 2025-03-11 | 188,249 | 518 | 369,462 | 51.0% |
| 2025-03-10 | 255,535 | 2 | 502,966 | 50.8% |
| 2025-03-07 | 281,931 | 2,761 | 509,532 | 55.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.